All PlansAdministrativeMedium impact
Recall: Atovaquone
UPMC Health Plan·Infectious Disease, Pulmonology, Oncology +3 more·Pharmacy
We identified it
Jun 20, 2026
Summary
Camber Pharmaceuticals has recalled Atovaquone Oral Suspension lot #E220182 (exp 12/2023) due to bacterial contamination. This medication is used for Pneumocystis jiroveci pneumonia prevention and treatment in patients who cannot tolerate other medicines.
Action Required
Immediately: Pharmacy staff must identify and quarantine any Atovaquone Oral Suspension lot #E220182 with expiration date 12/2023. Contact patients who received this lot and coordinate with prescribing providers for alternative therapy. Document recall compliance for audit purposes.